This seminar was jointly organized by A*STAR, DxD Hub and HSA. It aims to address concerns from the scientific and clinical community with regards to medical device regulatory framework and requirements, especially in Singapore. This is due to the importance of compliance to regulatory guidelines for the success in commercialization and clinical adoption of developed medical devices. This seminar is also for regulators, clinicians and engineers in the medical industry to network and engage one another on regulatory concerns. Ms Tan Hwee Ee was a key speaker in the forum and her speech covers the regulatory outline of US, EU and China.